Becton Dickinson (BDX)Officer sold ~$160K
Michael David Garrison, Officer at Becton Dickinson, sold ~$160K of Becton Dickinson shares.
- ~$160K
- Approx. value · 1,100 sh @ $145.66
- 13K
- Holds after · shares reported
- Traded
- Jun 24, 2026
- Filed
- Jun 25, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 9, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 15, 2025, the Company filed a Current Report on Form 8-K that reported that Vitor Roque, who previously served as the Company’s Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, was appointed as the Company’s interim Chief Financial Officer, effective December 5, 2025.”
- Mar 27, 2026CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
- Apr 27, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Apr 28, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 15, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 3.4%
- May 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
- May 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Jun 1, 2026InsiderCEO sold ~$405K of BDX shares in the open market
- Jun 10, 2026InsiderOfficer sold ~$167K of BDX shares in the open market
- Jun 24, 2026 · this disclosureInsiderOfficer sold ~$160K of BDX shares in the open market
What came next
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep" Foley Tray System Add-A-Foley Catheter REF: A153200 UDI code: 00801741121067¿ 10801741121064 SureStep" Fole…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bard¿ Foley Tray With Lubri-Sil¿ All-Silicone Foley Catheter REF: 947314 947316 947318 UDI codes: 00801741024924¿ 108…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bardex Lubricath Foley Catheter Tray REF: 899914 899916 899918 UDI codes: 00801741024801¿ 10801741024808 008017410248…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: (Canada Only) SureStep" Foley Tray System Bardex¿ IC Complete Care¿ REF: A300314AC UDI-DI code: 00801741143243 SureSt…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep Intermittent Catheter Tray REF: INTP16 INTS14 INTS14C INTS16 INTS16C PEDINTS06 PEDINTS08 PEDINTS10 UDI code:…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: *Bardex¿ I.C. Complete Care¿ Foley Catheter Tray REF: 300316A UDI codes: 00801741024344¿ 10801741024341 *Bardex¿ I.C.…
- Jun 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Jul 9, 2026FDARecall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTIO…
- Jul 10, 2026FDAFDA device clearance: Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 French (0092100); Blakemore Esophageal-Na…
- Jul 19, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
- Jul 27, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
- Jul 30, 2026FDARecall: BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35…
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 6, 20265% stakeFirst Eagle Investment Management, LLC reported a passive stake (13G) of 5.1%
- Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
- Aug 10, 2026FDARecall: Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605150; Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605200; Power-Trialysis Short…
- Aug 10, 2026FDARecall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625200; DuoGlide Short-Term Straight Dialys…
- Aug 11, 2026FDARecall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct moni…
- Aug 11, 2026InsiderOfficer sold ~$441K of BDX shares in the open market
- Aug 13, 2026InsiderCEO sold ~$768K of BDX shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
Other recent filings by Michael David Garrison, EVP & Pres Med.Essntl&BioPharm
- SEC Form 4 at Becton Dickinson (BDX)Jun 11, 2026
- SEC Form 4 at Becton Dickinson (BDX)Jan 16, 2026
- SEC Form 4 at Becton Dickinson (BDX)Jan 16, 2026
- SEC Form 4 at Becton Dickinson (BDX)Dec 18, 2025
- SEC Form 4 at Becton Dickinson (BDX)Jul 22, 2025
The full history of Michael David Garrison, EVP & Pres Med.Essntl&BioPharm is on the profile page.
How this filing works
Other disclosures at Becton Dickinson
- SEC Form 4Sep 30, 2026
- SEC Form 144Sep 28, 2026
- SEC Form 4Aug 27, 2026
- SEC Form 13F-HRAug 18, 2026
- SEC Form 4Aug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
